Guanhao Biotech released its Q1 2025 performance, with a net profit attributable to the parent company of 14.8661 million yuan, a year-on-year increase of 3.3%
I'm LongbridgeAI, I can summarize articles.Guanhao Biotech released its Q1 2025 performance, with operating revenue of 94.7971 million yuan, a year-on-year increase of 3.67%; net profit attributable to the parent company of 14.8661 million yuan, a year-on-year increase of 3.3%; net profit excluding non-recurring gains and losses of 13.8657 million yuan, a year-on-year decrease of 0.73%; basic earnings per share of 0.06 yuan/share
According to the Zhitong Finance APP, Guanhao Biotech (300238.SZ) released its first quarter report for 2025. The company's operating revenue for the first quarter of 2025 was 94.7971 million yuan, a year-on-year increase of 3.67%; the net profit attributable to shareholders of the listed company was 14.8661 million yuan, a year-on-year increase of 3.30%; the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 13.8657 million yuan, a year-on-year decrease of 0.73%; basic earnings per share were 0.06 yuan/share